AMERIPRISE FINANCIAL INC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 133 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2022$7,000
-63.2%
12,737
-58.6%
0.00%
Q4 2021$19,000
+26.7%
30,737
+112.6%
0.00%
Q3 2021$15,000
-44.4%
14,459
-2.8%
0.00%
Q2 2021$27,000
-12.9%
14,879
-4.3%
0.00%
Q1 2021$31,000
+47.6%
15,554
-9.8%
0.00%
Q4 2020$21,000
-76.9%
17,235
-66.2%
0.00%
Q3 2020$91,000
-76.5%
50,949
+10.5%
0.00%
Q2 2020$387,00046,1000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders